Brain abscess: about a clinical series of 30 patients

A retrospective study was designed to ascertain the main clinical features of 30 patients admitted for brain abscess between 1989 and 2005. A contiguous source of infection was identified in 40% of cases, direct inoculation secondary to trauma or neurosurgery in 23,3%, and a distant source in 23,3%....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista chilena de infectología 2006-06, Vol.23 (2), p.140
Hauptverfasser: Fica C, Alberto, Bustos G, Patricio, Miranda C, Gonzalo
Format: Artikel
Sprache:spa
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 140
container_title Revista chilena de infectología
container_volume 23
creator Fica C, Alberto
Bustos G, Patricio
Miranda C, Gonzalo
description A retrospective study was designed to ascertain the main clinical features of 30 patients admitted for brain abscess between 1989 and 2005. A contiguous source of infection was identified in 40% of cases, direct inoculation secondary to trauma or neurosurgery in 23,3%, and a distant source in 23,3%. Fever, headache and sensorial involvement were the main clinical manifestations. Temporal and frontal lesions were predominant. Microbiological information was available in only half of cases, prevailing polymicrobial and gram-positive bacterial infections. Most patients underwent surgical procedures (66.7%) and the rest received only medical therapy. During antimicrobial treatment, 6 patients (20%) suffered a serious adverse event that prompted discontinuation or change of therapy. Failure of treatment was observed in 40%, including 3 deaths (10%), non-programmed surgical drainage or reintervention (16.7%) and changes of the antimicrobial regimen (13.3%). Eight patients were discharged with sequels (26.7%), and during follow-up, 21% presented major events (death or brain abscess-related readmission).
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_16721448</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16721448</sourcerecordid><originalsourceid>FETCH-pubmed_primary_167214483</originalsourceid><addsrcrecordid>eNpjYeA0MDc00zU0MLTgYOAqLs4yMDAyNzM0ZGfgMDQzNzI0MbHgZDB1KkrMzFNITCpOTi0utgIy8ktLFBIVknMy8zKTE3MUilOLMlOLFfLTFIwNFAoSSzJT80qKeRhY0xJzilN5oTQ3g5yba4izh25BaVJuakp8QVFmbmJRZTzMHmOCCgDCxzFT</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Brain abscess: about a clinical series of 30 patients</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Fica C, Alberto ; Bustos G, Patricio ; Miranda C, Gonzalo</creator><creatorcontrib>Fica C, Alberto ; Bustos G, Patricio ; Miranda C, Gonzalo</creatorcontrib><description>A retrospective study was designed to ascertain the main clinical features of 30 patients admitted for brain abscess between 1989 and 2005. A contiguous source of infection was identified in 40% of cases, direct inoculation secondary to trauma or neurosurgery in 23,3%, and a distant source in 23,3%. Fever, headache and sensorial involvement were the main clinical manifestations. Temporal and frontal lesions were predominant. Microbiological information was available in only half of cases, prevailing polymicrobial and gram-positive bacterial infections. Most patients underwent surgical procedures (66.7%) and the rest received only medical therapy. During antimicrobial treatment, 6 patients (20%) suffered a serious adverse event that prompted discontinuation or change of therapy. Failure of treatment was observed in 40%, including 3 deaths (10%), non-programmed surgical drainage or reintervention (16.7%) and changes of the antimicrobial regimen (13.3%). Eight patients were discharged with sequels (26.7%), and during follow-up, 21% presented major events (death or brain abscess-related readmission).</description><identifier>ISSN: 0716-1018</identifier><identifier>PMID: 16721448</identifier><language>spa</language><publisher>Chile</publisher><subject>Adolescent ; Adult ; Aged ; Anti-Bacterial Agents - therapeutic use ; Brain Abscess - complications ; Brain Abscess - microbiology ; Brain Abscess - therapy ; Combined Modality Therapy ; Drainage ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors</subject><ispartof>Revista chilena de infectología, 2006-06, Vol.23 (2), p.140</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16721448$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fica C, Alberto</creatorcontrib><creatorcontrib>Bustos G, Patricio</creatorcontrib><creatorcontrib>Miranda C, Gonzalo</creatorcontrib><title>Brain abscess: about a clinical series of 30 patients</title><title>Revista chilena de infectología</title><addtitle>Rev Chilena Infectol</addtitle><description>A retrospective study was designed to ascertain the main clinical features of 30 patients admitted for brain abscess between 1989 and 2005. A contiguous source of infection was identified in 40% of cases, direct inoculation secondary to trauma or neurosurgery in 23,3%, and a distant source in 23,3%. Fever, headache and sensorial involvement were the main clinical manifestations. Temporal and frontal lesions were predominant. Microbiological information was available in only half of cases, prevailing polymicrobial and gram-positive bacterial infections. Most patients underwent surgical procedures (66.7%) and the rest received only medical therapy. During antimicrobial treatment, 6 patients (20%) suffered a serious adverse event that prompted discontinuation or change of therapy. Failure of treatment was observed in 40%, including 3 deaths (10%), non-programmed surgical drainage or reintervention (16.7%) and changes of the antimicrobial regimen (13.3%). Eight patients were discharged with sequels (26.7%), and during follow-up, 21% presented major events (death or brain abscess-related readmission).</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Brain Abscess - complications</subject><subject>Brain Abscess - microbiology</subject><subject>Brain Abscess - therapy</subject><subject>Combined Modality Therapy</subject><subject>Drainage</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><issn>0716-1018</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpjYeA0MDc00zU0MLTgYOAqLs4yMDAyNzM0ZGfgMDQzNzI0MbHgZDB1KkrMzFNITCpOTi0utgIy8ktLFBIVknMy8zKTE3MUilOLMlOLFfLTFIwNFAoSSzJT80qKeRhY0xJzilN5oTQ3g5yba4izh25BaVJuakp8QVFmbmJRZTzMHmOCCgDCxzFT</recordid><startdate>200606</startdate><enddate>200606</enddate><creator>Fica C, Alberto</creator><creator>Bustos G, Patricio</creator><creator>Miranda C, Gonzalo</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200606</creationdate><title>Brain abscess: about a clinical series of 30 patients</title><author>Fica C, Alberto ; Bustos G, Patricio ; Miranda C, Gonzalo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_167214483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Brain Abscess - complications</topic><topic>Brain Abscess - microbiology</topic><topic>Brain Abscess - therapy</topic><topic>Combined Modality Therapy</topic><topic>Drainage</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><toplevel>online_resources</toplevel><creatorcontrib>Fica C, Alberto</creatorcontrib><creatorcontrib>Bustos G, Patricio</creatorcontrib><creatorcontrib>Miranda C, Gonzalo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Revista chilena de infectología</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fica C, Alberto</au><au>Bustos G, Patricio</au><au>Miranda C, Gonzalo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Brain abscess: about a clinical series of 30 patients</atitle><jtitle>Revista chilena de infectología</jtitle><addtitle>Rev Chilena Infectol</addtitle><date>2006-06</date><risdate>2006</risdate><volume>23</volume><issue>2</issue><spage>140</spage><pages>140-</pages><issn>0716-1018</issn><abstract>A retrospective study was designed to ascertain the main clinical features of 30 patients admitted for brain abscess between 1989 and 2005. A contiguous source of infection was identified in 40% of cases, direct inoculation secondary to trauma or neurosurgery in 23,3%, and a distant source in 23,3%. Fever, headache and sensorial involvement were the main clinical manifestations. Temporal and frontal lesions were predominant. Microbiological information was available in only half of cases, prevailing polymicrobial and gram-positive bacterial infections. Most patients underwent surgical procedures (66.7%) and the rest received only medical therapy. During antimicrobial treatment, 6 patients (20%) suffered a serious adverse event that prompted discontinuation or change of therapy. Failure of treatment was observed in 40%, including 3 deaths (10%), non-programmed surgical drainage or reintervention (16.7%) and changes of the antimicrobial regimen (13.3%). Eight patients were discharged with sequels (26.7%), and during follow-up, 21% presented major events (death or brain abscess-related readmission).</abstract><cop>Chile</cop><pmid>16721448</pmid></addata></record>
fulltext fulltext
identifier ISSN: 0716-1018
ispartof Revista chilena de infectología, 2006-06, Vol.23 (2), p.140
issn 0716-1018
language spa
recordid cdi_pubmed_primary_16721448
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Adolescent
Adult
Aged
Anti-Bacterial Agents - therapeutic use
Brain Abscess - complications
Brain Abscess - microbiology
Brain Abscess - therapy
Combined Modality Therapy
Drainage
Female
Humans
Male
Middle Aged
Retrospective Studies
Risk Factors
title Brain abscess: about a clinical series of 30 patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T00%3A09%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Brain%20abscess:%20about%20a%20clinical%20series%20of%2030%20patients&rft.jtitle=Revista%20chilena%20de%20infectolog%C3%ADa&rft.au=Fica%20C,%20Alberto&rft.date=2006-06&rft.volume=23&rft.issue=2&rft.spage=140&rft.pages=140-&rft.issn=0716-1018&rft_id=info:doi/&rft_dat=%3Cpubmed%3E16721448%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16721448&rfr_iscdi=true